Lung Cancer Metastatic Clinical Trials
0 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 1
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
Lung CancerBrain MetastasesLung Cancer Metastatic
University of California, Davis20 enrolled1 locationNCT05452005
Recruiting
Phase 2
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Lung CancerBrain Metastases, AdultBrain Metastases+1 more
Memorial Sloan Kettering Cancer Center62 enrolled7 locationsNCT05419076
Recruiting
Not Applicable
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Lung CancerLung NeoplasmsLung Cancer Metastatic+2 more
RenJi Hospital100 enrolled1 locationNCT07026110
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Head and Neck CancerRenal Cell CarcinomaLung Cancer Metastatic
UNICANCER646 enrolled40 locationsNCT05078047
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Lung CancerLung Cancer Metastatic
Essen Biotech85 enrolled1 locationNCT06538012
Recruiting
Primary Tumor Resection for M1a Stage Lung Cancer
Lung Cancer MetastaticSurgical Resection
Fudan University66 enrolled1 locationNCT06547710
Recruiting
Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Lung Cancer MetastaticEGFR Gene Mutation
Collin Blakely38 enrolled1 locationNCT04085315
Recruiting
Phase 2
Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM)68 enrolled1 locationNCT04405401